Abstract:Coxsackievirus A6 (CVA6) and CVA10 are two of the major pathogens associated with hand, foot and mouth disease (HFMD) in children. The majority of CVA6 and CVA10 infections result in mild, self-limiting episodes (fever and herpangina) in pediatric populations; however, in some cases, can proceed to severe neurological disease and death. Efforts to mitigate viral transmission to decrease the morbidity and mortality associated with infection would be greatly strengthened by the availability of an efficacious CVA6 and CVA10 bivalent vaccine. Here we report the immunogenicity and protective efficacy of a bivalent combination vaccine comprised of formaldehyde-inactivated, whole-virus CVA6 and CVA10. We demonstrate that subcutaneous delivery of the bivalent vaccine can induce antigen-specific systemic immune responses, particularly the induction of polyfunctional T cells, which elicit active immunization to achieve a protection rate of >80% in the infected neonatal mice. Furthermore, passive transfer of the antisera from vaccinated mice potently protected recipient mice against CVA6 and CVA10 challenge. Importantly, the bivalent vaccine could induce high levels of IgG and neutralizing antibodies in adult female mice and the maternal antibody transmitted to the recipient mice played an important role in controlling homotypic and heterotypic CVA6 and CVA10 infections and viral replication in vivo. Collectively, these findings indicate that there is no immunological interference between the two antigens with respect to their ability to induce virus-specific immune responses, and thus provides proof-of-concept for further development of multivalent vaccines for broad protection against HFMD.

Comparative analysis of the biological characteristics of three CV‐A10 clones adaptively cultured on Vero cells

A comparative study on biological characteristics of ten coxsackievirus A10 virus strains

Evaluation of the Cross-Neutralization Activities Elicited by Coxsackievirus A10 Vaccine Strains.

Characterization of coxsackievirus A10 strains isolated from children with hand, foot, and mouth disease

Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine

The Establishment of Infectious Clone and Single Round Infectious Particles for Coxsackievirus A10

Comparative Pathogenicity of Coxsackievirus A16 Circulating and Noncirculating Strains in Vitro and in a Neonatal Mouse Model.

Screening of a new candidate coxsackievirus B1 vaccine strain based on its biological characteristics

Construction and Characterization of an Infectious Clone of Coxsackievirus A6 That Showed High Virulence in Neonatal Mice

The Development and Characterization of a Stable Coxsackievirus A16 Infectious Clone with Nanoluc Reporter Gene

VP1 Sequence Determination and Phylogenetic Analysis of Coxsackievirus A16 Strains

Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine

Development Of A Pseudovirus-Based Assay For Measuring Neutralizing Antibodies Against Coxsackievirus A10

Inactivated Coxsackievirus A10 Experimental Vaccines Protect Mice Against Lethal Viral Challenge

Development of an Efficient Neutralization Assay for Coxsackievirus A10

Characterization of an Inactivated Whole-Virus Bivalent Vaccine That Induces Balanced Protective Immunity Against Coxsackievirus A6 and A10 in Mice.

Poorly Neutralizing Polyclonal Antibody in Vitro Against Coxsackievirus A16 Circulating Strains Can Prevent a Lethal Challenge in Vivo.

Genetic Characteristics of the P1 Coding Region of Coxsackievirus A16 Associated with Hand, Foot, and Mouth Disease in China.

Amino acid substitutions in VP2, VP1, and 2C attenuate a Coxsackievirus A16 in mice

The structure of CVA10 virus procapsid particle

Pathogenic analysis of coxsackievirus A10 in rhesus macaques